Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 3
2010 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
López-Farré AJ, Sacristán D, Zamorano-León JJ, San-Martín N, Macaya C. López-Farré AJ, et al. Among authors: sacristan d. Cardiovasc Ther. 2008 Spring;26(1):65-74. doi: 10.1111/j.1527-3466.2007.00030.x. Cardiovasc Ther. 2008. PMID: 18466422 Free article. Review.
Different protein expression in normal and dysfunctional platelets from uremic patients.
Marques M, Sacristán D, Mateos-Cáceres PJ, Herrero J, Arribas MJ, González-Armengol JJ, Villegas A, Macaya C, Barrientos A, López-Farré AJ. Marques M, et al. Among authors: sacristan d. J Nephrol. 2010 Jan-Feb;23(1):90-101. J Nephrol. 2010. PMID: 20091492
Photochemical emission and fixation of NOX gases in soils.
Barrón V, Méndez JM, Balbuena J, Cruz-Yusta M, Sánchez L, Giménez C, Sacristán D, González-Guzmán A, Sánchez-Rodríguez AR, Skiba UM, Inda AV, Marques J Jr, Recio JM, Delgado A, Del Campillo MC, Torrent J. Barrón V, et al. Among authors: sacristan d. Sci Total Environ. 2020 Feb 1;702:134982. doi: 10.1016/j.scitotenv.2019.134982. Epub 2019 Nov 2. Sci Total Environ. 2020. PMID: 31733554
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
Sacristán D, López-Farré AJ, Zamorano-León JJ, Azcona L, Fernández-Ortiz A, Romero J, Farré J, Macaya C. Sacristán D, et al. J Cardiovasc Pharmacol. 2008 Mar;51(3):286-92. doi: 10.1097/FJC.0b013e318163a90f. J Cardiovasc Pharmacol. 2008. PMID: 18356694 Clinical Trial.
Direct effect of F12511, a systemic inhibitor of Acyl-CoA cholesterol acyltransferase on bovine aortic endothelial cells.
Zamorano-León JJ, Fernández-Sánchez R, López Farré AJ, Lapuente-Tiana L, Alonso-Orgaz S, Sacristán D, Junquera D, Delhon A, Conesa A, Mateos-Cáceres PJ, Macaya C. Zamorano-León JJ, et al. Among authors: sacristan d. J Cardiovasc Pharmacol. 2006 Sep;48(3):128-34. doi: 10.1097/01.fjc.0000246263.67515.6a. J Cardiovasc Pharmacol. 2006. PMID: 17031267
Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients.
Sacristán D, Marques M, Zamorano-León JJ, Luque M, Armengol J, Del Castillo J, Martín J, Delpón E, Ramos-Mozo P, de Prada TP, Tamargo J, Barrientos A, Macaya C, López-Farré A. Sacristán D, et al. Proteomics Clin Appl. 2008 Sep;2(9):1300-12. doi: 10.1002/prca.200700021. Epub 2008 Jul 21. Proteomics Clin Appl. 2008. PMID: 21136924
Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study.
López-Farré AJ, Mateos-Cáceres PJ, Sacristán D, Azcona L, Bernardo E, de Prada TP, Alonso-Orgaz S, Fernández-Arquero M, Fernández-Ortiz A, Macaya C. López-Farré AJ, et al. Among authors: sacristan d. J Proteome Res. 2007 Jul;6(7):2481-7. doi: 10.1021/pr060600i. Epub 2007 Jun 8. J Proteome Res. 2007. PMID: 17555340
Proteomic study of plasma from moderate hypercholesterolemic patients.
Alonso-Orgaz S, Moreno L, Macaya C, Rico L, Mateos-Cáceres PJ, Sacristán D, Pérez-Vizcaíno F, Segura A, Tamargo J, López-Farré A. Alonso-Orgaz S, et al. Among authors: sacristan d. J Proteome Res. 2006 Sep;5(9):2301-8. doi: 10.1021/pr060159w. J Proteome Res. 2006. PMID: 16944942
Feedback